Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
BAA FY26C1FP7 MD Anderson Oncology Center for Excellence (OCE), Evaluating Bayesian Effective Sample Size and Decision… is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by The Univeristy of Texas M.D. Anderson Cancer Center. Estimated value $752K ($752K obligated). Current period of performance ends Sep 29, 2028. Last award drew 1 bidder. Place of performance: HOUSTON TX. Related solicitation FDABAA -26- 00123.
Baa fy26c1fp7 md anderson oncology center for excellence (oce), evaluating bayesian effective sample size and decision criteria for pediatric and rare disease trials
Recompete timing
PublicCurrent PoP ends Sep 29, 2028 (713 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 29, 2027.
Want the durability read on 75F40126C00055? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordThe Univeristy of Texas M.D. Anderson Cancer Center — $28.1M obligated across 39 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40126C00055?
75F40126C00055 (OCE BAA fy26c1fp7 MD anderson) is a Fda Office Of Acq Grant Svcs award with a potential value of $752K, currently held by The Univeristy of Texas M.D. Anderson Cancer Center. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40126C00055?
Fda Office Of Acq Grant Svcs awarded 75F40126C00055 to The Univeristy of Texas M.D. Anderson Cancer Center (potential $752K).
Who is the incumbent on 75F40126C00055?
The Univeristy of Texas M.D. Anderson Cancer Center is the incumbent with $28.1M across 39 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2028.
When does The Univeristy of Texas M.D. Anderson Cancer Center’s 75F40126C00055 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75F40126C00055? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.